OMIX

[Gene result data] A Phase 3 Trial Comparing Selpercatinib to Cabozantinib or Vandetanib in Patients with RET-Mutant Medullary Thyroid Cancer(LIBRETTO-531)

OMIX005855

1Summary
Title [Gene result data] A Phase 3 Trial Comparing Selpercatinib to Cabozantinib or Vandetanib in Patients with RET-Mutant Medullary Thyroid Cancer(LIBRETTO-531)
Description JZJB_RET Concordance test & prescreening test gene data
Organism Homo sapiens
Data Type Other Type of Genomic Data
Data Accessibility Controlled-access
BioProject PRJCA023699
Release Date 2024-02-21
Submitter Minghua Ge (gemingh@163.com)
Organization Zhejiang Provincial People's Hospital
Submission Date 2024-02-20
2Files & Download

HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX005855-01 LIBRETTO-531-RET gene result data for concordance test 2 Other Type of Genomic Data 250.9 KB zip 0 Controlled
OMIX005855-02 LIBRETTO-531-RET gene result data for prescreening test 3 Other Type of Genomic Data 650.2 KB zip 0 Controlled

Request for this Data View All Released Data of OMIX